Viking Therapeutics Shares Fall on $200M Offerings of Stock, Notes
By Elias SchisgallShares of Viking Therapeutics fell after the biopharmaceutical company said it plans to offer $200 million each of common stock and convertible senior notes due 2032.Shares fell 8.2% to $38.24 in after-hours trading on Wednesday. The stock closed up 2% at $41.65, up 18% this year…